Literature DB >> 15372243

Establishment of permanent cell lines purified from human mesothelioma: morphological aspects, new marker expression and karyotypic analysis.

Marie-Marthe Philippeaux1, Jean-Claude Pache, Sophie Dahoun, Marc Barnet, John-Henri Robert, Jacques Mauël, Anastase Spiliopoulos.   

Abstract

This study reports the establishment of three major subtypes of human mesothelioma cells in tissue culture, i.e. the epithelioid, sarcomatoid and biphasic forms, and compares their phenotypic and biological characteristics. Primary cells isolated from biopsies or pleural exudates were subcultured for over 50 passages. We evaluated immunoreactivity using various mesothelial markers related to histological patterns of these cell lines. For epithelioid cells, calretinin and cytokeratin were found to be useful and easily interpretable markers as for control mesothelial cells. The biphasic form was only partially positive and the sarcomatoid type negative. Vimentin was expressed by all cell lines. BerEP4, a specific marker for adenocarcinoma, was negative. Interestingly, while the macrophage marker CD14 was negative, immunoreactivity for a mature macrophage marker (CD68) was expressed by all cell types, suggesting that this marker might constitute an additional tool useful in the differential diagnosis of mesothelioma. At the ultrastructural level, a cell surface rich in microvilli confirmed their mesothelial origin. PCR analysis revealed that none of the cell lines contained SV40 DNA. Karyotypic analyses showed more complex abnormalities in the epithelioid subtype than in the sarcomatoid form. These cell lines may be useful in the study of cellular, molecular and genetic aspects of the disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15372243     DOI: 10.1007/s00418-004-0701-1

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  56 in total

Review 1.  The cytology of malignant mesothelioma.

Authors:  D Whitaker
Journal:  Cytopathology       Date:  2000-06       Impact factor: 2.073

2.  Distribution of the CD68 macrophage/myeloid associated antigen.

Authors:  K A Pulford; A Sipos; J L Cordell; W P Stross; D Y Mason
Journal:  Int Immunol       Date:  1990       Impact factor: 4.823

Review 3.  Calretinin: a novel tool for diagnostic immunohistochemistry.

Authors:  A P Dei Tos; C Doglioni
Journal:  Adv Anat Pathol       Date:  1998-01       Impact factor: 3.875

4.  Differential expression of N-cadherin in pleural mesotheliomas and E-cadherin in lung adenocarcinomas in formalin-fixed, paraffin-embedded tissues.

Authors:  A C Han; A Peralta-Soler; K A Knudsen; M J Wheelock; K R Johnson; H Salazar
Journal:  Hum Pathol       Date:  1997-06       Impact factor: 3.466

Review 5.  The mesothelium and its reactions: a review.

Authors:  D Whitaker; J M Papadimitriou; M N Walters
Journal:  Crit Rev Toxicol       Date:  1982-04       Impact factor: 5.635

6.  E-cadherin, N-cadherin, and calretinin in pleural effusions: the good, the bad, the worthless.

Authors:  A Simsir; P Fetsch; D Mehta; M Zakowski; A Abati
Journal:  Diagn Cytopathol       Date:  1999-03       Impact factor: 1.582

7.  The immunohistochemical diagnostic panel for epithelial mesothelioma: a reevaluation after heat-induced epitope retrieval.

Authors:  J R Riera; C Astengo-Osuna; J A Longmate; H Battifora
Journal:  Am J Surg Pathol       Date:  1997-12       Impact factor: 6.394

8.  Thrombomodulin expression in malignant pleural mesothelioma and pulmonary adenocarcinoma.

Authors:  C L Collins; N G Ordonez; R Schaefer; C D Cook; S S Xie; J Granger; P L Hsu; L Fink; S M Hsu
Journal:  Am J Pathol       Date:  1992-10       Impact factor: 4.307

9.  KP1 (CD 68) staining of malignant melanomas.

Authors:  F Facchetti; G Bertalot; P G Grigolato
Journal:  Histopathology       Date:  1991-08       Impact factor: 5.087

10.  Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers.

Authors:  K Chang; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

View more
  10 in total

Review 1.  Recent progress in histochemistry and cell biology: the state of the art 2005.

Authors:  Douglas J Taatjes; Jürgen Roth
Journal:  Histochem Cell Biol       Date:  2005-11-11       Impact factor: 4.304

Review 2.  News and views in Histochemistry and Cell Biology.

Authors:  Esther Asan; Detlev Drenckhahn
Journal:  Histochem Cell Biol       Date:  2004-12-22       Impact factor: 2.531

3.  Human malignant mesothelioma is recapitulated in immunocompetent BALB/c mice injected with murine AB cells.

Authors:  Rosanna Mezzapelle; Eltjona Rrapaj; Elena Gatti; Chiara Ceriotti; Francesco De Marchis; Alessandro Preti; Antonello E Spinelli; Laura Perani; Massimo Venturini; Silvia Valtorta; Rosa Maria Moresco; Lorenza Pecciarini; Claudio Doglioni; Michela Frenquelli; Luca Crippa; Camilla Recordati; Eugenio Scanziani; Hilda de Vries; Anton Berns; Roberta Frapolli; Renzo Boldorini; Maurizio D'Incalci; Marco E Bianchi; Massimo P Crippa
Journal:  Sci Rep       Date:  2016-03-10       Impact factor: 4.379

4.  Gremlin-1 is a key regulator of the invasive cell phenotype in mesothelioma.

Authors:  Miao Yin; Mira Tissari; Jenni Tamminen; Irene Ylivinkka; Mikko Rönty; Pernilla von Nandelstadh; Kaisa Lehti; Marko Hyytiäinen; Marjukka Myllärniemi; Katri Koli
Journal:  Oncotarget       Date:  2017-10-06

5.  Experimental Model of Human Malignant Mesothelioma in Athymic Mice.

Authors:  Didier J Colin; David Cottet-Dumoulin; Anna Faivre; Stéphane Germain; Frédéric Triponez; Véronique Serre-Beinier
Journal:  Int J Mol Sci       Date:  2018-06-26       Impact factor: 5.923

6.  Pemetrexed-loaded nanoparticles targeted to malignant pleural mesothelioma cells: an in vitro study.

Authors:  Emanuela Cova; Laura Pandolfi; Miriam Colombo; Vanessa Frangipane; Simona Inghilleri; Monica Morosini; Simona Mrakic-Sposta; Sarah Moretti; Manuela Monti; Ymera Pignochino; Silvia Benvenuti; Davide Prosperi; Giulia Stella; Patrizia Morbini; Federica Meloni
Journal:  Int J Nanomedicine       Date:  2019-01-23

7.  Variation in drug sensitivity of malignant mesothelioma cell lines with substantial effects of selenite and bortezomib, highlights need for individualized therapy.

Authors:  Adam Szulkin; Gustav Nilsonne; Filip Mundt; Agata M Wasik; Pega Souri; Anders Hjerpe; Katalin Dobra
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

8.  Phenotypes and karyotypes of human malignant mesothelioma cell lines.

Authors:  Vandana Relan; Leanne Morrison; Kylie Parsonson; Belinda E Clarke; Edwina E Duhig; Morgan N Windsor; Kevin S Matar; Rishendran Naidoo; Linda Passmore; Elizabeth McCaul; Deborah Courtney; Ian A Yang; Kwun M Fong; Rayleen V Bowman
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240

9.  Role of MIF/CD74 signaling pathway in the development of pleural mesothelioma.

Authors:  Cintia D'Amato-Brito; Davide Cipriano; Didier J Colin; Stéphane Germain; Yann Seimbille; John H Robert; Frédéric Triponez; Véronique Serre-Beinier
Journal:  Oncotarget       Date:  2016-03-08

Review 10.  Use of preclinical models for malignant pleural mesothelioma.

Authors:  Marie Shamseddin; Joanna Obacz; Mathew J Garnett; Robert Campbell Rintoul; Hayley Elizabeth Francies; Stefan John Marciniak
Journal:  Thorax       Date:  2021-03-10       Impact factor: 9.139

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.